Generic Drug Makers Did Not Violate Antitrust Law: Jury
Ending a long-running antitrust dispute that went all the way to the Federal Circuit and back, a California jury has ruled that generic drug maker Sandoz Inc. did not violate antitrust...To view the full article, register now.
Already a subscriber? Click here to view full article